Short term vaccine reactions due to mixing and matching of COVID-19 vaccines
- Conditions
- Reactogenicity of vaccine
- Registration Number
- SLCTR/2022/008
- Lead Sponsor
- Public Sector Medical College, Rawalpindi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 448
Adults 18 years of age or older
- Men and women
- Healthy or with stable chronic medical conditions specifically including asthma, stable HIV, hepatitis B virus, or hepatitis C virus infection, will be eligible for participation in the trial while all rest comorbidities will be an exclusion.
- Must have history of 2 times homologous vaccine intervention of BBIBP-CorV vaccine.
- People with known comorbidities (Diabetes, hypertension, heart diseases, chronic respiratory diseases
like bronchiectasis, COPD etc) except those mentioned above in inclusion.
- People who will have not received homologous vaccine two doses of BBIBP-CorV vaccine or those
whose previous medical record of last 2 doses will be missing .
- Difference between homologous vaccine and heterologous vaccine if less than 6 months
- Pregnancy
- History of flu or cough at that time
- Medical history of COVID-19 at time of trial
- On immunosuppressive therapy
- Diagnosed with an immunocompromising condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method